(Q51594608)

7 April 2018

title

Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity. (English)

1 reference

7 April 2018

author name string

T R Pieber

1

1 reference

7 April 2018

J Roitelman

2

1 reference

7 April 2018

Y Lee

3

1 reference

7 April 2018

K L Luskey

4

1 reference

7 April 2018

D T Stein

5

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 July 1994

1 reference

7 April 2018

American Journal of Physiology

published in

1 reference

7 April 2018

volume

267

1 reference

7 April 2018

issue

1 Pt 1

1 reference

7 April 2018

page(s)

E156-64

1 reference

7 April 2018

Coordinate Regulation of Amylin and Insulin Expression in Response to Hypoglycemia and Fasting

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Regional distribution and molecular forms of rat islet amyloid polypeptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

In vitro reversal of the fasting state of liver metabolism in the rat. Reevaluation of the roles of insulin and glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Genetically transmitted obesity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

In vitro effects of amylin on carbohydrate metabolism in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Amylin and insulin co-replacement therapy for insulin-dependent (type I) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Secretion of islet amyloid polypeptide in response to glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Feedback inhibition of insulin gene expression by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Developmental regulation of amylin and insulin-gene expression in lean (Fa/Fa) and obese (fa/fa) Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Rat amylin: cloning and tissue-specific expression in pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

The effects of amylin on carbohydrate metabolism in skeletal muscle in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Decrease of Stimulated Amylin Release Precedes Impairment of Insulin Secretion in Type II Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Statistical estimation of the minimal detectable concentration ("sensitivity") for radioligand assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Amylin inhibits insulin-stimulated glucose uptake in C2C12 muscle cell line through a cholera-toxin-sensitive mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Islet amyloid polypeptide--a novel controversy in diabetes research

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRP alpha) in the fasted, anaesthetized rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.1994.267.1.E156

10.1152/AJPENDO.1994.267.1.E156

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

release_g5wbr374g5aene3gcntiop6a5m

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g5wbr374g5aene3gcntiop6a5m

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

8048505

1 reference

7 April 2018